Novira Therapeutics Inc., of Radnor, Pa., completed a second round of seed funding to bring its early financing total to about $2.5 million, with another $1 million obtained in nondilutive grants. The latest financing was led by Philadelphia angel groups Delaware Crossing Investor Group, the Mid-Atlanta Angel Group Fund II and Robin Hood Ventures.